Studies conducted in vitro revealed that estrogen, either alone on combined with progesterone, can increase TET3 expression in human endometrial epithelial cells (HES) and elevate TET3 protein levels in endometrial adenocarcinoma cell lines (AN3) [46]. Here, TET3 is linked to endometrium adenocarcinoma.